"the phase transformation" trang 11 - tải miễn phí từ tailieuXANH
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
7    55    0
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial
10    54    0
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
8    52    0
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: A dose-finding phase 1 trial

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: A dose-finding phase 1 trial
7    54    0
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial
7    65    0
Multipartite disentanglement dynamics due simultaneously to amplitude damping and phase damping

Multipartite disentanglement dynamics due simultaneously to amplitude damping and phase damping
17    65    0
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study
8    56    0
Neovascularization of hepatocellular carcinoma in a nude mouse orthotopic liver cancer model: A morphological study using X-ray in-line phase-contrast imaging

Neovascularization of hepatocellular carcinoma in a nude mouse orthotopic liver cancer model: A morphological study using X-ray in-line phase-contrast imaging
11    48    0
PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)

PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)
8    49    0
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials

Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials
9    55    0
Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy

Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy
10    48    0
Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer: A multicenter randomized phase III clinical trial (SENORITA trial) protocol

Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer: A multicenter randomized phase III clinical trial (SENORITA trial) protocol
8    174    0
Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study
10    49    0
Effects of MgO on dielectric relaxation and phase transition of the ceramic matrix BaBi4Ti4O15

Effects of MgO on dielectric relaxation and phase transition of the ceramic matrix BaBi4Ti4O15
10    56    0
Comparison of essay type and multiple choice questions for theoretical formative assessment among second phase MBBS students in microbiology

Comparison of essay type and multiple choice questions for theoretical formative assessment among second phase MBBS students in microbiology
9    81    0
Doctoral thesis summary: The factors impact on accounting benefits in the post-implementation phase in enterprise resource planning (ERP) system in Viet Nam firms

Doctoral thesis summary: The factors impact on accounting benefits in the post-implementation phase in enterprise resource planning (ERP) system in Viet Nam firms
23    63    0
A randomized phase II study of weekly nabpaclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: The AFUGEM GERCOR trial

A randomized phase II study of weekly nabpaclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: The AFUGEM GERCOR trial
11    69    0
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
13    52    0
Randomized phase II study of S-1 dosing schedule for resected colorectal cancer

Randomized phase II study of S-1 dosing schedule for resected colorectal cancer
4    45    0
Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: A multi-institutional phase II randomised clinical trial

Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: A multi-institutional phase II randomised clinical trial
8    71    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.